SF3A3 and non-small cell lung carcinoma: We found that the half-life of SF3A3 protein in NSCLC cells with circSCAP overexpression was much shorter than that of control cells (Fig. 6A-C), implying that circSCAP could weaken the stability of SF3A3 protein.